Rosacea Awareness Month, Healthy Minority Month, and a quick look ahead to 2027. 
View in browser
LiVDerm Newsletter - A Dose of News

April 2026

Facebook
LinkedIn
X
Instagram
YouTube

✨ April Awareness Spotlights

Rosacea Awareness Month

April is Rosacea Awareness Month, a time to highlight and increase understanding of this often misunderstood condition. Despite its prevalence, rosacea is frequently underdiagnosed or mismanaged, with many patients experiencing delays in diagnosis or ineffective treatment approaches. Ongoing education plays a critical role in helping clinicians recognize early signs, personalize treatment plans, and improve long-term patient outcomes.

National Healthy Minority Month

National Healthy Minority Month offers an opportunity to reinforce the importance of advancing health equity and improving outcomes across diverse patient populations. In dermatology, this includes enhancing our ability to recognize variations in how conditions present across skin types, understanding differences in disease manifestation, addressing disparities in access to care, and building cultural competence in clinical practice.

 

Together, let's use this month to raise awareness, expand our understanding, and continue to support patient-centered care for all skin types and communities.

🌟 Looking Ahead: SBS & MOPD 2027

Planning is already underway for the 2027 South Beach Symposium (SBS) and Masters of Pediatric Dermatology (MOPD) - milestone years celebrating 25 and 35 years of excellence, respectively.

 

Registration is now open, and the earlier you register, the more you save with our early bird pricing. If these meetings are part of your annual education calendar, it's a great time to start planning ahead. If not, consider this your sign to see what everyone’s been talking about. 😉

South Beach Symposium
Register for SBS
Masters of Pediatric Dermatology
Register for MOPD

Stay tuned to your inbox for more details coming soon.

📚 Featured CME Activity

Explore these CME activities before they close: 

Expanding the AD Toolb-OX

Discover emerging approaches and therapeutic pathways to enhance management of moderate-to-severe atopic dermatitis.

Start Activity

JAK is Out of the Box

Examine the evolving role of JAK inhibitors and practical strategies for treating diverse patient populations with severe alopecia areata.

Start Activity

📄 Featured Blogs

Dermatology Clinical Trials

Dermatology Clinical Trials: Why Participation Matters

Drug-Associated Bullous Pemphigoid

Drug-Associated Bullous Pemphigoid: Potential Triggers and Pathophysiological Pathways

Supporting Families, Raising Awareness

Supporting Families, Raising Awareness: Spotlight on Global Parents for Eczema Research

📰 Recent Articles

Managing Cutaneous Adverse Events in GLP-1 Patients

"Promising Results" for Anti-IL-18 Protein Targeting Atopic Dermatitis

Clarifying Psoriasis: New Position Statement by The National Psoriasis Foundation Redefines Disease Severity

FDA Approves Secukinumab for Adolescent Hidradenitis Suppurativa

📲 Let's Connect

Stay inspired and in the know-connect with us for the latest updates, expert tips, and exclusive offers!

Facebook
LinkedIn
X
Instagram
Facebook
LinkedIn
X / Twitter
Instagram
YouTube

This is an educational message from LiVDerm.
1801 N. Military Trail, Suite 110  •  Boca Raton, FL 33431, United States  •  561-893-8625
You are subscribed to this newsletter with the email address %user_email%.
To unsubscribe click here.